![Richard Hoyt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Hoyt
Vorsitzender bei
ZYUS LIFE SCIENCES CORPORATION
Vermögen: 15 759 $ am 31.05.2026
Profil
Mr. Richard Hoyt is a Chairman at ZYUS Life Sciences Corp., a Vice President-Business Development at Xeris Biopharma Holdings, Inc., a Chairman at ZYUS Life Sciences, Inc. and a Managing Partner at Ozark Transaction Advisors LLC.
Mr. Hoyt was previously employed as an Independent Director by CanniMed Therapeutics, Inc., a Vice President-Business Development & Licensing by Mallinckrodt Plc, and a Vice President-Business Development by Xeris Pharmaceuticals, Inc. He also served on the board at Biotechnology Research & Development Corp.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.11.2025 | 309’002 ( 0.39% ) | 15 759 $ | 31.05.2026 |
Aktive Positionen von Richard Hoyt
| Unternehmen | Position | Beginn |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Vorsitzender | 01.09.2020 |
| XERIS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | 01.11.2019 |
ZYUS Life Sciences, Inc.
 ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical manufacturing company | Vorsitzender | - |
Ozark Transaction Advisors LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Richard Hoyt
| Unternehmen | Position | Ende |
|---|---|---|
| MALLINCKRODT PLC | Corporate Officer/Principal | 01.09.2018 |
| CANNIMED THERAPEUTICS INC | Direktor/Vorstandsmitglied | 15.03.2018 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Corporate Officer/Principal | - |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Provides research on animal and plant healthcare, material sciences and biotechnology | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Provides research on animal and plant healthcare, material sciences and biotechnology | Commercial Services |
CanniMed Therapeutics, Inc.
 CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in production of pharmaceutical grade cannabis products | Health Technology |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical manufacturing company | Health Technology |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
ZYUS Life Sciences Corp.
 ZYUS Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes cannabinoid-based pharmaceutical drug product candidates and therapeutics | Health Technology |
Ozark Transaction Advisors LLC |
